Drugs / ORDOPIDINE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01023282 | Nov 2009 → Apr 2011 | Parkinson disease | NeuroSearch A/S | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ORDOPIDINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545010 ↗ |
| Known as | ACR325 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01023282 ↗ |
| Known as | Ordopidina | ChEMBL registry synonym — accepted as the source's own label CHEMBL3545010 ↗ |
| Modality | Small molecule | — CHEMBL3545010 ↗ |
| Target | DRD2 | “Dopamine D2 receptor modulator” CHEMBL3545010 ↗ |